Mechanisms to diversify repertoire and modify T cell activity after infection
Mechanisms to diversify repertoire and modify T cell activity after infection
批准号:
9319117
负责人:
Paul G. Thomas
金额:
$45.54万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-01 至 2019-07-31
关键词:
AcuteAgeAllelesAnimalsAntiviral AgentsAutoimmunityB-LymphocytesBar CodesBiologicalCD3 AntigensCell Culture TechniquesCell CycleCell LineageCellsChronicDataDevelopmentEventGenerationsGenetic TranscriptionHost DefenseHumanImmune responseImmune systemImmunityImmunologic MemoryIn VitroIndividualInfectionInflammationInfluenzaMaintenanceMature T-LymphocyteMeasuresMessenger RNAMethodsModelingMusPeripheralPlasticizersPlayReceptor SignalingRegulationReportingRoleSamplingSignal TransductionStimulusT cell responseT-Cell Antigen Receptor SpecificityT-Cell ReceptorT-LymphocyteTechnologyTestingThymus GlandTransgenic OrganismsViralVirusVirus Diseasesadaptive immunityagedimmune functionin vivoin vivo Modelinnovationnovelpathogenpublic health relevancereceptorresponsetheories
中文摘要
描述(申请人提供):与B细胞不同,一旦完全成熟的T细胞离开胸腺,T细胞受体的谱系通常被认为是固定的。我们最近开发了一项技术,可以从小鼠和人类的单个细胞中检测成对的��T细胞受体的信息并对其进行排序。这一方法允许两个重要的观察:1)在急性和记忆免疫反应过程中,两条TCRA链转录信息的细胞比例显著不同;2)体内T细胞的克隆性谱系证明了外周受体的修订。采用创新的体外单细胞培养平台,独一无二
在活体模型中,包括条件性RAG缺陷小鼠和一组有价值的纵向人类样本,我们建议扩展这些观察,以评估对病毒感染的最佳T细胞反应需要固有的可塑性外周系统的假设。我们的三个
目的验证以下假设:1)双TCRCD3等位基因表达通过干扰帧内等位基因转录和/或TCRCD3组装来调节TcR信号强度和功能T细胞活性;2)大多数NA�ve T细胞外周TcR修饰性是由强TcR信号诱导的;3)在急、慢性感染(流感和巨细胞病毒)中,双等位基因表达和修饰性都是T细胞最佳活性所必需的。这些研究结合了一套新的体外技术和体内模型,将导致对如何产生和调节最佳抗病毒T细胞反应的新理解,对我们理解获得性免疫具有广泛的意义。
英文摘要
DESCRIPTION (provided by applicant): In contrast to B cells, the T cell receptor repertoire is generally considered fixed once fully mature T cells exit the thymus. We recently developed the technology to detect and sequence the message of paired �� T cell receptors from single cells in mice and humans. This approach permitted two important observations: 1) the proportion of cells transcribing message for two Tcra chains varies dramatically over the course of acute and memory immune responses and 2) clonal lineages of T cells in vivo demonstrate evidence of receptor revision in the periphery. Using innovative in vitro single cell culture platforms, unique
in vivo models including conditional RAG-deficient mice, and a valuable panel of longitudinal human samples, we propose to extend these observations to assess the hypothesis that optimal T cell responses to viral infections require an inherently plastic peripheral repertoire. Our three
aims test the specific hypotheses that 1) Dual TCR� allele expression regulates TCR signal strength and functional T cell activity by interfering with in frame allele transcription and/or TCR:CD3 assembly, 2) Peripheral TCR revision is induced in most na�ve T cells by strong TCR signaling and 3) Both dual allele expression and revision are required for optimal T cell activity in acute and chronic infections (influenza and mCMV). These studies combine a suite of novel in vitro technology and in vivo models that will result in a new understanding of how optimal antiviral T cell responses are generated and regulated, with broad implications for our understanding of adaptive immunity.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3389/fimmu.2018.01071
发表时间:
2018
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[Souquette A, Thomas PG]
通讯作者:
Thomas PG
DOI:
10.1371/journal.ppat.1004642
发表时间:
2015-02
期刊:
PLoS pathogens
影响因子:
6.7
作者:
[Duan S, Meliopoulos VA, McClaren JL, Guo XZ, Sanders CJ, Smallwood HS, Webby RJ, Schultz-Cherry SL, Doherty PC, Thomas PG]
通讯作者:
Thomas PG
DOI:
10.4049/jimmunol.1701413
发表时间:
2018-01-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Zamora AE, Crawford JC, Thomas PG]
通讯作者:
Thomas PG
Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8⁺ T cells.
严重 H7N9 疾病的恢复与 CD8 T 细胞主导的多种反应机制有关
DOI:
10.1038/ncomms7833
发表时间:
2015-05-13
期刊:
NATURE COMMUNICATIONS
影响因子:
16.6
作者:
[Wang, Zhongfang, Wan, Yanmin, Qiu, Chenli, Quinones-Parra, Sergio, Zhu, Zhaoqin, Loh, Liyen, Tian, Di, Ren, Yanqin, Hu, Yunwen, Zhang, Xiaoyan, Thomas, Paul G., Inouye, Michael, Doherty, Peter C., Kedzierska, Katherine, Xu, Jianqing]
通讯作者:
Xu, Jianqing
DOI:
10.3389/fimmu.2016.00025
发表时间:
2016
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[Duan S, Thomas PG]
通讯作者:
Thomas PG
共 8 条
Neoantigen-specific T cell responses for Fibrolamellar Hepatocellular Carcinoma
-
批准号:10609918
-
项目类别:
-
资助金额:$70.3万
-
财政年份:2023
-
负责人:Paul G. Thomas
-
依托单位:
Neoantigen-specific T cell responses for Fibrolamellar Hepatocellular Carcinoma
-
批准号:10467512
-
项目类别:
-
资助金额:$73.33万
-
财政年份:2022
-
负责人:Paul G. Thomas
-
依托单位:
Decoding the interactions between T cell receptors and peptide-MHC
-
批准号:10406323
-
项目类别:
-
资助金额:$68.19万
-
财政年份:2018
-
负责人:Paul G. Thomas
-
依托单位:
DECODING THE INTERACTIONS BETWEEN T CELL RECEPTORS AND PEPTIDE-MHC
-
批准号:10682160
-
项目类别:
-
资助金额:$89.07万
-
财政年份:2018
-
负责人:Paul G. Thomas
-
依托单位:
Decoding the interactions between T cell receptors and peptide-MHC
-
批准号:10158266
-
项目类别:
-
资助金额:$68.19万
-
财政年份:2018
-
负责人:Paul G. Thomas
-
依托单位:
A protective role for gamma delta T cells in respiratory infection
-
批准号:9234456
-
项目类别:
-
资助金额:$45.45万
-
财政年份:2016
-
负责人:Paul G. Thomas
-
依托单位:
A protective role for gamma delta T cells in respiratory infection
-
批准号:9113835
-
项目类别:
-
资助金额:$45.84万
-
财政年份:2016
-
负责人:Paul G. Thomas
-
依托单位:
Mechanisms to diversify repertoire and modify T cell activity after infection
-
批准号:8573498
-
项目类别:
-
资助金额:$45.04万
-
财政年份:2013
-
负责人:Paul G. Thomas
-
依托单位:
Mechanisms to diversify repertoire and modify T cell activity after infection
-
批准号:8709989
-
项目类别:
-
资助金额:$45.54万
-
财政年份:2013
-
负责人:Paul G. Thomas
-
依托单位:
Quantifying and modeling influenza viral dynamics and host responses
-
批准号:8321729
-
项目类别:
-
资助金额:$64.81万
-
财政年份:2011
-
负责人:Paul G. Thomas
-
依托单位:
Immunodominance hierarchies and compensation in influenza specific CD8+ T cell re
-
批准号:7530465
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2009
-
负责人:Paul G. Thomas
-
依托单位:
Immunodominance hierarchies and compensation in influenza specific CD8+ T cell re
-
批准号:7937978
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2009
-
负责人:Paul G. Thomas
-
依托单位:
Antigen-specific CD4+ T cell responses to influenza
-
批准号:6936903
-
项目类别:
-
资助金额:$4.4万
-
财政年份:2005
-
负责人:Paul G. Thomas
-
依托单位:
Antigen-specific CD4+ T cell responses to influenza
-
批准号:7084639
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2005
-
负责人:Paul G. Thomas
-
依托单位:
Antigen-specific CD4+ T cell responses to influenza
-
批准号:7257111
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2005
-
负责人:Paul G. Thomas
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: